Skip to main content

Cell Harvesting Market Sales and Volume 2020 with Status and Prospect to 2023

Cell Harvesting Market Overview
Cell harvesting is performed by separating the cell culture from the growing medium, involving techniques such as centrifugation, microfiltration, and depth filtration. The term cell harvesting is generally used with reference to stem cells.
Stem cells are primitive cells that have the capacity to develop into different cell types. There are various types of stem cells that are segmented by their ability to differentiate and origin. Bone marrow transplantation is an instance of a stem cell therapy that has gained wide acceptance worldwide. Cell harvesting is done by separating the cell culture from the growing medium, involving methods such as microfiltration, depth filtration, and centrifugation.
The Worldwide cell harvesting market is estimated to record a CAGR of 8.75% with an approximate market value of USD 209.5 million over the forecast period 2018 to 2023.
Key Players
Key players are leading the market actively with new product launches. However, the complicated functioning of harvesters, collectively with ethical issues associated with embryonic stem cell research may restrict the market growth. Strict government regulations and mandatory licensing norms may also limit the market growth over the forecast period.
The key players in the global cell harvesting market include names such as
  • Avita Medical
  • ads-tec GmbH
  • Arthrex Inc.
  • Argos Technologies Inc.
  • connectorate
  • Bertin
  • hynoDent AG
  • Cox Scientific
  • Scinomix
  • Teleflex Incorporated
  • Terumo Corporation
  • and PerkinElmer Inc.
Factors such as increase in diseases, increase in chronic infections, rapid growth of the pharmaceutical and biotechnology sectors, and growing research in regenerative medicines are anticipated to boost the market growth.
Market Segmentation
The worldwide cell harvesting market has been segmented into application, end user, and product type.
Based on application, the market has been segmented into stem cell research, biopharmaceutical application, and others.
Based on product type, the market has been segmented into automated cell harvesters and manual cell harvesters. The manual cell harvesters segment is likely to hold the highest share in the market. The automated cell harvesters segment is a rapidly growing segment due to surge in the application of automated technology in devices and increased awareness about the device.
Based on end user, the market has been segmented into research institutes, biotechnology companies, pharmaceutical companies, and others.
Intended Audience
  • Pharmaceutical companies
  • Biotechnology companies
  • Cell harvester vendors
  • Research and Development (R&D) companies
  • Government research institutes
  • Academic institutes and universities
Access Premium Report Page along with Table of Content and List of Figures@ https://www.marketresearchfuture.com/reports/cell-harvesting-market-6801
Regional Analysis
The Americas are likely to dominate the worldwide cell harvesting market owing to an improved healthcare sector and surging healthcare expenditure. In May 2018, data published by the Committee for a Responsible Federal Budget reported that the US expended almost 18% of its Gross Domestic Product (GDP) on health expenditures which amounted to USD 3.5 trillion approximately. Additionally, several players in this region focus on developing new treatment options, making it a lucrative option for the development of market in this region.
Europe is likely to hold the second largest position in the global cell harvesting market. Availability of funds for research plays an active role in driving the growth of the market in Europe. The data published by the National Institute of Health Funding (NIHR) in 2016 recorded that funding of EUR 928 million had been announced for new NIHR Clinical Research Facilities (CRF) and NIHR Biomedical Research Centers (BRC) for five years commencing from April 2017.
Asia-Pacific is likely to be the fastest growing market owing to the developing economies such as India and China. Plus, the presence of a huge patient population in these regions also drives the cell harvesting market in this region.
The Middle East and Africa is known to hold the least share of the market. However, the Middle Eastern market appears promising owing to the increasing government initiatives.
At Market Research Future (MRFR), Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more